Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
Type
Public
HQ
San Francisco, US
Founded
2009
Size (employees)
7 (est)
UNITY Biotechnology was founded in 2009 and is headquartered in San Francisco, US
Report incorrect company information

Key People/Management at UNITY Biotechnology

Keith R. Leonard

Keith R. Leonard

CEO
Bob Goeltz

Bob Goeltz

CFO
Nathaniel David

Nathaniel David

President
Jamie Dananberg

Jamie Dananberg

Chief Medical Officer
D. Dan Marquess

D. Dan Marquess

Chief Scientific Officer
Tamara Tompkins

Tamara Tompkins

General Counsel
Show more

UNITY Biotechnology Office Locations

UNITY Biotechnology has an office in San Francisco
Show all (1)
Report incorrect company information

UNITY Biotechnology Financials and Metrics

UNITY Biotechnology Revenue

Market capitalization (3-Aug-2018)

646.6 m

Closing stock price (3-Aug-2018)

15.3
UNITY Biotechnology's current market capitalization is $646.6 m.
Show all financial metrics
Report incorrect company information

UNITY Biotechnology Online and Social Media Presence

Embed Graph
Report incorrect company information

UNITY Biotechnology Company Life and Culture

Report incorrect company information